Observational studyAnnals of African medicine2025
Arteriovenous Thrombosis among Severe Acute Respiratory Syndrome Coronavirus 2 Infected Patients: An Observational Study at a University Hospital.
Observational study in Annals of African medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Scoping review about pathogenesis, risk factors, and treatment of venous and arterial thrombosis in coronavirus infection.Frontiers in cardiovascular medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextThe global spread of severe acute respiratory syndrome coronavirus 2 since its emergence in 2019 has led to widespread challenges in healthcare, prompting the World Health Organization to declare it a pandemic.
aimThe aims of this study were to explore the prevalence of arterio-venous thrombosis (AVT) in COVID-19 patients, along with baseline characteristics and predictors of AVT. SETTINGS AND
designThis retrospective cohort study review of charts from adult patients presenting between March 1, 2020, and October 30, 2021, at King Fahd Hospital of the University. SUBJECTS AND
methodsPatients with both AVT and COVID-19 were included and categorized into groups: brain stroke, myocardial infarction (MI), pulmonary embolism (PE), and deep venous thrombosis (DVT). Demographic and clinical data were collected from electronic medical records, and patients were followed up 1 year after discharge. STATISTICAL ANALYSIS USED: SPSS was used.
resultsFive hundred nine adult patients were admitted with COVID-19, and 195 were diagnosed with AVT. Brain stroke, MI, PE, and DVT were observed in 48.7%, 25.6%, 10.8%, and 14.9% of cases, respectively. Risk factors such as hypertension, diabetes, dyslipidemia, and smoking were more prevalent among stroke patients. Follow-up revealed varying mortality rates and recurrent AVT cases among different AVT syndromes.
conclusionsThe study highlights a higher incidence of AVT, particularly brain stroke, in COVID-19-positive patients, with overlapping AVT syndromes observed. The findings emphasize the intricate relationship between COVID-19 and AVT, necessitating further research and targeted interventions to address this critical aspect of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.